Skip to main content
Erschienen in: Journal of Neurology 10/2023

17.07.2023 | Review

Efficacy and safety of noninvasive brain stimulation for patients with cerebellar ataxia: a systematic review and meta-analysis of randomized controlled trials

verfasst von: Cheng Gong, Yi Long, Xu-Miao Peng, Hao Hu, Jing Chen, Li Xiao, Yan-Biao Zhong, Mao-Yuan Wang, Yun Luo

Erschienen in: Journal of Neurology | Ausgabe 10/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

With the development of noninvasive brain stimulation (NIBS) techniques, many researchers have turned their attention to NIBS as a promising treatment for cerebellar ataxia. Therefore, we conducted a systematic review and meta-analysis to investigate the efficacy and safety of NIBS in treating patients with cerebellar ataxia.

Methods

Databases, including PubMed, Embase, Web of Science, Medline, and Cochrane Library, were retrieved for relevant randomized controlled trials (RCTs). Two researchers conducted literature screening, data extraction, literature quality assessment, and heterogeneity analysis between RCTs. According to the magnitude of heterogeneity I2, an appropriate data analysis model was selected for meta-analysis.

Results

A total of 14 RCTs including 406 patients with cerebellar ataxia met the inclusion criteria. The included RCTs had an overall low-risk bias and an intermediate level of evidence recommendation for key outcome indicators, such as the scale for the assessment and rating of ataxia (SARA) and international cooperative ataxia rating scale (ICARS). The results of meta-analysis showed that cerebellar NIBS, including transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS), was effective in reducing the SARA scores (MD = − 3.45, 95%CI = [− 4.85, − 2.50], P < 0.05) and ICARS scores (MD = − 10.87, 95%CI = [− 14.46, − 7.28], P < 0.05) in patients with cerebellar ataxia compared to controls. Subgroup analysis showed that the efficacy of tDCS and rTMS was statistically different in patients with cerebellar ataxia as assessed by the SARA scores, but not by the ICARS scores. There was statistically significant difference in the efficacy of NIBS for the treatment of cerebellar ataxia caused by different etiologies. As for safety, 8 of 14 included studies documented the adverse effects of NIBS, and only two studies reported the mild adverse events of NIBS.

Conclusions

Cerebellar NIBS was safe and effective in improving the motor coordination of patients with cerebellar ataxia, and tDCS was better than rTMS in the treatment of cerebellar ataxia. In addition, the efficacy of NIBS was different in the treatment of different types of cerebellar ataxia.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Brusse E, Maat-Kievit JA, van Swieten JC (2007) Diagnosis and management of early- and late-onset cerebellar ataxia. Clin Genet 71(1):12–24CrossRefPubMed Brusse E, Maat-Kievit JA, van Swieten JC (2007) Diagnosis and management of early- and late-onset cerebellar ataxia. Clin Genet 71(1):12–24CrossRefPubMed
2.
3.
6.
Zurück zum Zitat Zesiewicz TA et al (2018) Comprehensive systematic review summary: treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 90(10):464–471CrossRefPubMedPubMedCentral Zesiewicz TA et al (2018) Comprehensive systematic review summary: treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 90(10):464–471CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Liberati A et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100CrossRefPubMedPubMedCentral Liberati A et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Goldet G, Howick J (2013) Understanding GRADE: an introduction. J Evid Based Med 6(1):50–54CrossRefPubMed Goldet G, Howick J (2013) Understanding GRADE: an introduction. J Evid Based Med 6(1):50–54CrossRefPubMed
11.
Zurück zum Zitat Guyatt G et al (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64(4):383–394CrossRefPubMed Guyatt G et al (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64(4):383–394CrossRefPubMed
13.
Zurück zum Zitat Cha HG (2017) The effect of low-frequency (1 Hz) rTMS on the cerebellar cortex in patients with ataxia after a posterior circulation stroke: randomized control trial. J Magn 22(4):625–629CrossRef Cha HG (2017) The effect of low-frequency (1 Hz) rTMS on the cerebellar cortex in patients with ataxia after a posterior circulation stroke: randomized control trial. J Magn 22(4):625–629CrossRef
14.
Zurück zum Zitat Kim WS et al (2014) Effect of repetitive transcranial magnetic stimulation over the cerebellum on patients with ataxia after posterior circulation stroke: a pilot study. J Rehabil Med 46(5):418–423CrossRefPubMed Kim WS et al (2014) Effect of repetitive transcranial magnetic stimulation over the cerebellum on patients with ataxia after posterior circulation stroke: a pilot study. J Rehabil Med 46(5):418–423CrossRefPubMed
15.
Zurück zum Zitat França C et al (2020) Effects of cerebellar transcranial magnetic stimulation on ataxias: a randomized trial. Parkinsonism Relat Disord 80:1–6CrossRefPubMed França C et al (2020) Effects of cerebellar transcranial magnetic stimulation on ataxias: a randomized trial. Parkinsonism Relat Disord 80:1–6CrossRefPubMed
16.
Zurück zum Zitat Chen TX et al (2021) The efficacy and safety of transcranial direct current stimulation for cerebellar ataxia: a systematic review and meta-analysis. Cerebellum 20(1):124–133CrossRefPubMedPubMedCentral Chen TX et al (2021) The efficacy and safety of transcranial direct current stimulation for cerebellar ataxia: a systematic review and meta-analysis. Cerebellum 20(1):124–133CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Song P et al (2020) Repetitive transcranial magnetic stimulation of the cerebellum improves ataxia and cerebello-fronto plasticity in multiple system atrophy: a randomized, double-blind, sham-controlled and TMS-EEG study. Aging (Albany NY) 12(20):20611–20622CrossRefPubMed Song P et al (2020) Repetitive transcranial magnetic stimulation of the cerebellum improves ataxia and cerebello-fronto plasticity in multiple system atrophy: a randomized, double-blind, sham-controlled and TMS-EEG study. Aging (Albany NY) 12(20):20611–20622CrossRefPubMed
18.
Zurück zum Zitat Manor B et al (2019) Repetitive transcranial magnetic stimulation in spinocerebellar ataxia: a pilot randomized controlled trial. Front Neurol 10:73 (electronic resource)CrossRefPubMedPubMedCentral Manor B et al (2019) Repetitive transcranial magnetic stimulation in spinocerebellar ataxia: a pilot randomized controlled trial. Front Neurol 10:73 (electronic resource)CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Shiga Y et al (2002) Transcranial magnetic stimulation alleviates truncal ataxia in spinocerebellar degeneration. J Neurol Neurosurg Psychiatry 72(1):124–126CrossRefPubMedPubMedCentral Shiga Y et al (2002) Transcranial magnetic stimulation alleviates truncal ataxia in spinocerebellar degeneration. J Neurol Neurosurg Psychiatry 72(1):124–126CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Benussi A et al (2015) Cerebellar transcranial direct current stimulation in patients with ataxia: a double-blind, randomized, sham-controlled study. Mov Disord 30(12):1701–1705CrossRefPubMed Benussi A et al (2015) Cerebellar transcranial direct current stimulation in patients with ataxia: a double-blind, randomized, sham-controlled study. Mov Disord 30(12):1701–1705CrossRefPubMed
21.
Zurück zum Zitat Maas R et al (2022) Cerebellar transcranial direct current stimulation in spinocerebellar ataxia type 3: a randomized, double-blind, sham-controlled trial. Neurotherapeutics 02:02 Maas R et al (2022) Cerebellar transcranial direct current stimulation in spinocerebellar ataxia type 3: a randomized, double-blind, sham-controlled trial. Neurotherapeutics 02:02
22.
Zurück zum Zitat Benussi A et al (2018) Cerebello-spinal tDCS in ataxia: a randomized, double-blind, sham-controlled, crossover trial. Neurology 91(12):e1090–e1101CrossRefPubMed Benussi A et al (2018) Cerebello-spinal tDCS in ataxia: a randomized, double-blind, sham-controlled, crossover trial. Neurology 91(12):e1090–e1101CrossRefPubMed
23.
Zurück zum Zitat Benussi A et al (2017) Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia. Brain Stimul 10(2):242–250CrossRefPubMed Benussi A et al (2017) Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia. Brain Stimul 10(2):242–250CrossRefPubMed
25.
Zurück zum Zitat Benussi A et al (2021) Motor and cognitive outcomes of cerebello-spinal stimulation in neurodegenerative ataxia. Brain 144(8):2310–2321CrossRefPubMed Benussi A et al (2021) Motor and cognitive outcomes of cerebello-spinal stimulation in neurodegenerative ataxia. Brain 144(8):2310–2321CrossRefPubMed
26.
Zurück zum Zitat Barretto TL et al (2019) Transcranial direct current stimulation in the treatment of cerebellar ataxia: a two-phase, double-blind, auto-matched, pilot study. Clin Neurol Neurosurg 182:123–129CrossRefPubMed Barretto TL et al (2019) Transcranial direct current stimulation in the treatment of cerebellar ataxia: a two-phase, double-blind, auto-matched, pilot study. Clin Neurol Neurosurg 182:123–129CrossRefPubMed
27.
Zurück zum Zitat Joo BE, Lee CN, Park KW (2012) Prevalence rate and functional status of cerebellar ataxia in Korea. Cerebellum 11(3):733–738CrossRefPubMed Joo BE, Lee CN, Park KW (2012) Prevalence rate and functional status of cerebellar ataxia in Korea. Cerebellum 11(3):733–738CrossRefPubMed
28.
Zurück zum Zitat Marchina S et al (2021) Transcranial direct current stimulation for post-stroke dysphagia: a systematic review and meta-analysis of randomized controlled trials. J Neurol 268(1):293–304CrossRefPubMed Marchina S et al (2021) Transcranial direct current stimulation for post-stroke dysphagia: a systematic review and meta-analysis of randomized controlled trials. J Neurol 268(1):293–304CrossRefPubMed
29.
Zurück zum Zitat Elsner B, Kugler J, Mehrholz J (2020) Transcranial direct current stimulation (tDCS) for improving aphasia after stroke: a systematic review with network meta-analysis of randomized controlled trials. J Neuroeng Rehabil 17(1):88CrossRefPubMedPubMedCentral Elsner B, Kugler J, Mehrholz J (2020) Transcranial direct current stimulation (tDCS) for improving aphasia after stroke: a systematic review with network meta-analysis of randomized controlled trials. J Neuroeng Rehabil 17(1):88CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Yao L et al (2020) Low-frequency repetitive transcranial magnetic stimulation in patients with poststroke aphasia: systematic review and meta-analysis of its effect upon communication. J Speech Lang Hear Res 63(11):3801–3815CrossRefPubMed Yao L et al (2020) Low-frequency repetitive transcranial magnetic stimulation in patients with poststroke aphasia: systematic review and meta-analysis of its effect upon communication. J Speech Lang Hear Res 63(11):3801–3815CrossRefPubMed
31.
Zurück zum Zitat De Risio L et al (2020) Recovering from depression with repetitive transcranial magnetic stimulation (rTMS): a systematic review and meta-analysis of preclinical studies. Transl Psychiatry 10(1):393CrossRefPubMedPubMedCentral De Risio L et al (2020) Recovering from depression with repetitive transcranial magnetic stimulation (rTMS): a systematic review and meta-analysis of preclinical studies. Transl Psychiatry 10(1):393CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Lefaucheur JP et al (2017) Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clin Neurophysiol 128(1):56–92CrossRefPubMed Lefaucheur JP et al (2017) Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clin Neurophysiol 128(1):56–92CrossRefPubMed
33.
Zurück zum Zitat Choi JH et al (2022) Placebo response in degenerative cerebellar ataxias: a descriptive review of randomized, placebo-controlled trials. J Neurol 269(1):62–71CrossRefPubMed Choi JH et al (2022) Placebo response in degenerative cerebellar ataxias: a descriptive review of randomized, placebo-controlled trials. J Neurol 269(1):62–71CrossRefPubMed
Metadaten
Titel
Efficacy and safety of noninvasive brain stimulation for patients with cerebellar ataxia: a systematic review and meta-analysis of randomized controlled trials
verfasst von
Cheng Gong
Yi Long
Xu-Miao Peng
Hao Hu
Jing Chen
Li Xiao
Yan-Biao Zhong
Mao-Yuan Wang
Yun Luo
Publikationsdatum
17.07.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 10/2023
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-023-11799-8

Weitere Artikel der Ausgabe 10/2023

Journal of Neurology 10/2023 Zur Ausgabe

Neurological Update

An update on optic neuritis

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.